Literature DB >> 30607016

TET2 stabilization by 14-3-3 binding to the phosphorylated Serine 99 is deregulated by mutations in cancer.

Hao Chen1,2, Dingdang Yu1, Rui Fang3, Kimberlie Rabidou3, Di Wu3, Di Hu3, Peilin Jia4, Zhongming Zhao4, Zhiping Wu5, Junmin Peng5, Yang Shi2, Yujiang Geno Shi6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30607016      PMCID： PMC6460428          DOI： 10.1038/s41422-018-0132-5

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  7 in total

Review 1.  Mechanisms that regulate the activities of TET proteins.

Authors:  Kanak Joshi; Shanhui Liu; Peter Breslin S J; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2022-06-15       Impact factor: 9.207

Review 2.  TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.

Authors:  Yihong Guan; Metis Hasipek; Anand D Tiwari; Jaroslaw P Maciejewski; Babal K Jha
Journal:  Semin Hematol       Date:  2020-12-28       Impact factor: 3.851

3.  USP15 suppresses tumor immunity via deubiquitylation and inactivation of TET2.

Authors:  Lei-Lei Chen; Matthew D Smith; Lei Lv; Tadashi Nakagawa; Zhijun Li; Shao-Cong Sun; Nicholas G Brown; Yue Xiong; Yan-Ping Xu
Journal:  Sci Adv       Date:  2020-09-18       Impact factor: 14.136

Review 4.  Dysregulated TET Family Genes and Aberrant 5mC Oxidation in Breast Cancer: Causes and Consequences.

Authors:  Bo Xu; Hao Wang; Li Tan
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.639

5.  14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation.

Authors:  Anirban Kundu; Sandeep Shelar; Arindam P Ghosh; Mary Ballestas; Richard Kirkman; Hyeyoung Nam; Garrett J Brinkley; Suman Karki; James A Mobley; Sejong Bae; Sooryanarayana Varambally; Sunil Sudarshan
Journal:  J Biol Chem       Date:  2020-01-03       Impact factor: 5.157

Review 6.  TETology: Epigenetic Mastermind in Action.

Authors:  Ashikh Seethy; Karthikeyan Pethusamy; Indranil Chattopadhyay; Ramkishor Sah; Anita Chopra; Ruby Dhar; Subhradip Karmakar
Journal:  Appl Biochem Biotechnol       Date:  2021-03-10       Impact factor: 2.926

7.  PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen.

Authors:  Samantha L Tinsley; Brittany L Allen-Petersen
Journal:  NAR Cancer       Date:  2022-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.